Conversely, miR-101 is found downregulated in both types of ALCL, but, because it targets the mammalian/mechanistic target of the rapamycin (mTOR) pathway, its forced expression only affects ALK+ cell growth [176]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.